{"id":862610,"date":"2025-06-23T09:23:27","date_gmt":"2025-06-23T13:23:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/"},"modified":"2025-06-23T09:23:27","modified_gmt":"2025-06-23T13:23:27","slug":"firefly-neuroscience-to-be-added-to-the-russell-microcap-index","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/","title":{"rendered":"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>\u2013 Comes less than a year after listing on Nasdaq \u2013<\/em>\n      <\/p>\n<p align=\"justify\">KENMORE, N.Y., June  23, 2025  (GLOBE NEWSWIRE) &#8212; Firefly Neuroscience, Inc. (\u201cFirefly\u201d or the \u201cCompany\u201d) (NASDAQ: AIFF), an Artificial Intelligence (\u201cAI\u201d) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that it will be added to the Russell Microcap<sup>\u00ae<\/sup> Index as part of this year\u2019s reconstitution. The additions will be made effective after the U.S. market opens on June 30, 2025.<\/p>\n<p align=\"justify\">Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Russell&#8217;s U.S. indexes serve as the benchmark for approximately $10.6 trillion in assets as of the close of June 2024. Russell indexes are part of FTSE Russell, the global index provider.<\/p>\n<p align=\"justify\">\u201cBeing included among the companies that comprise the Russell indexes is a major milestone for Firefly, which we believe reflects the significant progress we have made since completing our reverse merger and listing on Nasdaq less than a year ago,\u201d said Greg Lipschitz, CEO of Firefly. \u201cSo far in 2025 alone, we have: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=buNlb4a_VLoJ7hhWHo4F6wlQm7Qq4jvD-8fybwOylOEad_-uyMoneO5rOW-zh7YBcaPcywhyizrb3H1fYeGVELBbsl0ASCeLTIGi_CRE47040SGJC55ACVILCzqkrOfueXwPwe2PcrQbH_5jopW1uRA3gv5lq5BnTxVRPjt3VclOvFGoMTXSVPtNh64j18LLafFsneQeYKSFpuW9QdhV3NDdKJnRICZZ_YCXGDVo60pRtw2Rsw6Z4NsH2LGk_X5sN-M5O8imet5L_xdv5CCwxXBnnj5oyHXQbv_Dnh8kgLg7IWQKB8qKVESVvi5iOEX2MrZ51_e41iTrmL_lzgCqABc_W3uQmh-EQCdB7baQbkY=\" rel=\"nofollow\" target=\"_blank\">discovered a breakthrough cognitive brain age biomarker<\/a> using our FDA-cleared BNA\u2122 Platform; been <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JJrwO5VEmwMHXYASKi-K-wnzWwMui-eb90_FSwxI-Jc3ryGCyge3-Fma_KR-s1QxUvlsDWUGzGiBP-Abu5aLvSyUFAFArPOQ6M5GZe5ojjXdbUccyGfO0DRyvR4rzaanx8rEPT-u0Tg63VEXL05JRbmkoycs2T_n5IJmv6nNxpNz-P6J5jnXcshC75QAK8eLHIGo88mWRJHkjrn960DJETaviIHqLKbdpk_t8XdDkmEhpmid5059Aj8oeyELJnnTtE9ZHn1Af1_cGJvLab2lfQ==\" rel=\"nofollow\" target=\"_blank\">accepted into the prestigious NVIDIA Connect program<\/a>; achieved multi-fold database, IP portfolio, and commercial footprint expansion through our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q9o3wwVEBkF3QTq0JU_POdjlSKuMMKNQdE0XiBUYA_GWCUAsrw7NGnbm71RQkku_zBtOfexSytHA6cixwZ8g22jLPwuqr-6LyH-HNQf_seI_4Nhn__e9UszwkUwud9MHanR_hFBTl9IjHDKBdLbmagn1GEncUhSaR9QgM5Stbip0VAX_D1wTH-HEatD3kJxrSBN6h56173nbVEnGWlQBlch_dJboKpH9fY7lPkkCptonaFWXvtASwzwaJ2c0fUC8imwYcxAeubrTqR89RrS-kvVTvZKX9QQsoMl-W6Mk7LUwcvtETny4x53rDb6TacuTF0RgyApw1HEYYvrbKEskdaPZJ5ZilYNfn9CvprlRnfapegixB_TwWc2VHLwgCxqMhfIgzoX2rnIpKaDIcMsBnw==\" rel=\"nofollow\" target=\"_blank\">acquisition of Evoke Neuroscience<\/a>; and, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=41sNBte1pDtuVTs4eauDWmn80ygyIxCEQgcz12R5ho5n4osehFhsRF-7Qt-HX-KxUGpAYS9QHGumOfs2e0P0_116vedtDllHxyFe4JKmzJedfGpCsMHtSEGEvY5ySMcqfNJ_B5oFzty8FEsbutF6TirS_VIg_5Y3NL9cuaMpu8w0G3UixmoJtddaWk4FzkLdHbuY2mpLHFwCyEemOsul5G58l2DbE-BdZ9QiXQaEsN_j9WcmWKpfIjM9VTNQDdbP8f7NZRBTjXspJSUTPFvmSmBRy381-wYHht9BCzMAo0qbZe1nMSNQk9YJ-2D-dUChu_1Z7xPke7US-CwmfSXslgfP9npuNWe-op41ak1UOJccjcuIVK8TGgnk4Qmk2lA0\" rel=\"nofollow\" target=\"_blank\">uncovered a powerful new way of objectively distinguishing<\/a> between subjective cognitive decline, mild cognitive impairment, and dementia in Alzheimer\u2019s patients.\u201d<\/p>\n<p align=\"justify\">Mr. Lipschitz added, \u201cMoving forward, our membership in the Russell Microcap<sup>\u00ae<\/sup> Index should increase our visibility among both institutional and retail investors at a pivotal time as we continue to execute our growth plans and work to achieve the many potential value-creating milestones we see ahead.\u201d<\/p>\n<p align=\"justify\">Each index within the Russell U.S. Indexes is reconstituted each year to capture the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization and grouping them according to certain criteria. Membership in the Russell Microcap<sup>\u00ae<\/sup> Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.<\/p>\n<p><strong>About Firefly<\/strong><br \/>Firefly (NASDAQ: AIFF) is an Artificial Intelligence (\u201cAI\u201d) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly\u2019s FDA-510(k) cleared Brain Network Analytics (BNA\u2122) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has built a comprehensive database of brain wave tests, securing patent protection, and achieving FDA clearance. The Company is now launching BNA\u2122 commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use.<\/p>\n<p align=\"justify\">Brain Network Analytics was developed using artificial intelligence and machine learning on Firefly\u2019s extensive proprietary database of standardized, high-definition longitudinal electroencephalograms (EEGs) of over 17,000 patients representing twelve disorders, as well as clinically normal patients. BNA\u2122, in conjunction with an FDA-cleared EEG\/ERP system, can provide clinicians with comprehensive insights into brain function. These insights can enhance a clinician\u2019s ability to accurately diagnose mental and cognitive disorders and to evaluate what therapy and\/or drug is best suited to optimize a patient\u2019s outcome.<\/p>\n<p align=\"justify\">Please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9PIuhtj91ODw5BfA-fqiXNNDmDJQ9IkjjEyrbQabLWk1bWoSuKx9XqYavW6N0XohSayrEzbGFR2GMuQjZLN-3EzvFZpIcTPNOBSIJlyScZKwFND8Xr2CdIjuEb-WrxRMK9g4C62sDArOr8aVgYZv79NpTbPF9EmH2p04Uf9ffRcTcaiQ_-weuqoWrdBapOD0nZYK6c78tqUaHWFiCUh-NDCgAtkPONCwREt2bOaRAiji0iWNTIi1dKNIzMmdiTEcQCJmR9mSiP87hM9XH65-PQ==\" rel=\"nofollow\" target=\"_blank\">https:\/\/fireflyneuro.com\/<\/a>\u00a0for more information.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>Certain statements in this press release may constitute \u201cforward-looking statements\u201d for purposes of the federal securities laws concerning Firefly. These forward-looking statements include express or implied statements relating to Firefly\u2019s management teams\u2019 expectations, hopes, beliefs, intentions, or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpossible,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cwould\u201d and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are based on current expectations and beliefs concerning future developments and their potential effects. There can be no assurance that future developments affecting Firefly will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond Firefly\u2019s control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to those factors described under the heading \u201cRisk Factors\u201d in the reports and other filings of Firefly with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of Firefly\u2019s assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. It is not possible to predict or identify all such risks. Forward-looking statements included in this press release only speak as of the date they are made, and Firefly does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.<\/p>\n<p>\n        <strong>Investor &amp; Media Contact<\/strong><br \/>\n        <br \/>Stephen Kilmer<br \/>(646) 274-3580<br \/>stephen.kilmer@fireflyneuro.com\u00a0 \u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OGE1YjA5NTYtYjc0Yi00MjkxLTljMDItMzcwZGE4ZmJkZTIzLTEzMDM4MzQtMjAyNS0wNi0yMy1lbg==\/tiny\/Firefly-Neuroscience-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u2013 Comes less than a year after listing on Nasdaq \u2013 KENMORE, N.Y., June 23, 2025 (GLOBE NEWSWIRE) &#8212; Firefly Neuroscience, Inc. (\u201cFirefly\u201d or the \u201cCompany\u201d) (NASDAQ: AIFF), an Artificial Intelligence (\u201cAI\u201d) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that it will be added to the Russell Microcap\u00ae Index as part of this year\u2019s reconstitution. The additions will be made effective after the U.S. market opens on June 30, 2025. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Russell&#8217;s U.S. indexes serve as the benchmark for approximately $10.6 trillion in assets as of the close of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-862610","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"\u2013 Comes less than a year after listing on Nasdaq \u2013 KENMORE, N.Y., June 23, 2025 (GLOBE NEWSWIRE) &#8212; Firefly Neuroscience, Inc. (\u201cFirefly\u201d or the \u201cCompany\u201d) (NASDAQ: AIFF), an Artificial Intelligence (\u201cAI\u201d) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that it will be added to the Russell Microcap\u00ae Index as part of this year\u2019s reconstitution. The additions will be made effective after the U.S. market opens on June 30, 2025. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Russell&#8217;s U.S. indexes serve as the benchmark for approximately $10.6 trillion in assets as of the close of &hellip; Continue reading &quot;Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-23T13:23:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index\",\"datePublished\":\"2025-06-23T13:23:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/\"},\"wordCount\":882,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/\",\"name\":\"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=\",\"datePublished\":\"2025-06-23T13:23:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/","og_locale":"en_US","og_type":"article","og_title":"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index - Market Newsdesk","og_description":"\u2013 Comes less than a year after listing on Nasdaq \u2013 KENMORE, N.Y., June 23, 2025 (GLOBE NEWSWIRE) &#8212; Firefly Neuroscience, Inc. (\u201cFirefly\u201d or the \u201cCompany\u201d) (NASDAQ: AIFF), an Artificial Intelligence (\u201cAI\u201d) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that it will be added to the Russell Microcap\u00ae Index as part of this year\u2019s reconstitution. The additions will be made effective after the U.S. market opens on June 30, 2025. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Russell&#8217;s U.S. indexes serve as the benchmark for approximately $10.6 trillion in assets as of the close of &hellip; Continue reading \"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-23T13:23:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index","datePublished":"2025-06-23T13:23:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/"},"wordCount":882,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/","name":"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=","datePublished":"2025-06-23T13:23:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MjY1NiM3MDEzMDgyIzIyOTIyODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/firefly-neuroscience-to-be-added-to-the-russell-microcap-index\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Firefly Neuroscience to be Added to the Russell Microcap\u00ae Index"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/862610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=862610"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/862610\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=862610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=862610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=862610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}